Biocytogen Licenses VHH Antibody to Qilu for Neuroscience Research
Biocytogen Pharmaceuticals has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical to support the research and development of a fully human VHH antibody for…
Read More...
Read More...
